{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-002614","form_type":"8-K","ticker":"BBNX","cik":"0001674632","company_name":"Beta Bionics, Inc.","filed_at":"2026-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.713324+00:00","generated_at":"2026-05-15T05:07:22.288678+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"medium","headline":"Beta Bionics Q1 net sales up 57% YoY to $27.6M; raises FY 2026 guidance","bullets":["Net sales $27.6M (+57% YoY); PBP channel $10.7M (+181% YoY).","Gross margin 59.5% (+864 bps); loss from ops $24.3M (-88% of sales vs -106%).","Net loss $21.9M vs $28.7M YoY; adjusted EBITDA -$17.7M (-64% vs -88% of sales).","Cash and investments $239.5M; raised full year 2026 guidance (quantified details not provided).","New patient starts declined 10-20% sequentially; 70% from MDI users."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-002614","json":"https://secwatch.observer/filing/0001171843-26-002614.json","markdown":"https://secwatch.observer/filing/0001171843-26-002614.md","text":"https://secwatch.observer/filing/0001171843-26-002614.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674632/000117184326002614/0001171843-26-002614-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674632/000117184326002614/f8k_042126.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:07:22.288678+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ad0f9cb11231cc07c0d64ff7bdf87fac2a638d87","claim":"Beta Bionics, Inc. updated its the quarter ended March 31, 2026 guidance (raised).","evidence_excerpt":"Beta Bionics, Inc. (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2026.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1674632/000117184326002614/0001171843-26-002614-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2026"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}